MindMaze Therapeutics Holding SA Share Price
Stocks
RLF
CH1251125998
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe Europe
16:20:00 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.1260 CHF | -4.98% |
|
-8.23% | -93.31% |
| 11-17 | MindMaze Therapeutics Locks In Up to CHF4 Million Investments for Platform Deployment | MT |
| 11-17 | Mindmaze Therapeutics Holding Sa Announces CHF 4 Million Financing | CI |
| Market Cap | 22.54M 26.73M 24.35M 20.39M 38.25M 2.5B 40.03M 272M 108M 1.35B 100M 98.17M 4.27B | P/E 2026 * |
-2.01x | P/E 2027 * | 2.65x |
|---|---|---|---|---|---|
| Enterprise Value | 17.37M 20.59M 18.76M 15.71M 29.47M 1.92B 30.84M 210M 83.26M 1.04B 77.25M 75.63M 3.29B | EV / Sales 2026 * |
5.63x | EV / Sales 2027 * | 0.53x |
| Free-Float |
34.81% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| RLF | Delayed | |
| 0QKQ | Real-time | ||
| MMTZF | Delayed | ||
| V6M | Delayed | ||
| V6M | Delayed | ||
| V6M | Real-time |
| 1 day | -4.07% | ||
| 1 week | -8.23% | ||
| Current month | -14.40% | ||
| 1 month | -14.63% | ||
| 3 months | -32.98% | ||
| 6 months | -70.42% | ||
| Current year | -93.31% |
| 1 week | 0.13 | 0.14 | |
| 1 month | 0.13 | 0.17 | |
| Current year | 0.13 | 1.87 | |
| 1 year | 0.13 | 2.92 | |
| 3 years | 0.13 | 2.92 | |
| 5 years | 0.13 | 2.92 | |
| 10 years | 0.13 | 2.92 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/12/25 | Sell | 140,000 | 0.0908% | |||
| 19/12/25 | Sell | 52,162 | 0.0338% | |||
| 19/12/25 | Sell | 281,968 | 0.1830% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.98% | -8.23% | - | - | 26.73M | ||
| -2.49% | -6.35% | +51.07% | +64.95% | 65.42B | ||
| -0.51% | -2.80% | +6.33% | +89.44% | 58.91B | ||
| -2.05% | -2.16% | +22.94% | +82.42% | 55.24B | ||
| -0.73% | -4.95% | +13.35% | +110.73% | 45.66B | ||
| -0.55% | -6.58% | +14.08% | +20.65% | 41.29B | ||
| -0.93% | +1.67% | +20.83% | +45.03% | 36.82B | ||
| +2.83% | -4.34% | +135.86% | +658.49% | 34.48B | ||
| -0.80% | +0.61% | +77.26% | +56.26% | 32.5B | ||
| +1.10% | +20.19% | -27.06% | +491.47% | 31.69B | ||
| Average | -0.80% | -1.09% | +34.96% | +179.94% | 40B | |
| Weighted average by Cap. | -0.70% | -1.28% | +33.03% | +153.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.09M 3.66M 3.33M 2.79M 5.24M 342M 5.48M 37.3M 14.8M 185M 13.73M 13.44M 585M | 28.23M 33.47M 30.5M 25.54M 47.91M 3.13B 50.14M 341M 135M 1.69B 126M 123M 5.35B |
| Net income | -8.29M -9.83M -8.96M -7.5M -14.07M -918M -14.72M -100M -39.75M -496M -36.88M -36.1M -1.57B | 10.38M 12.3M 11.21M 9.38M 17.61M 1.15B 18.43M 125M 49.75M 621M 46.15M 45.18M 1.97B |
| Net Debt | -5.18M -6.14M -5.59M -4.68M -8.78M -573M -9.19M -62.57M -24.82M -310M -23.02M -22.54M -981M | -7.65M -9.07M -8.26M -6.92M -12.98M -847M -13.58M -92.46M -36.68M -458M -34.03M -33.31M -1.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | CHF 0.1264 | -4.68% | 875,410 |
| 19/11/26 | CHF 0.1326 | -1.49% | 404,255 |
| 18/11/26 | CHF 0.1346 | -2.32% | 739,251 |
| 17/11/26 | CHF 0.1378 | -1.43% | 398,461 |
| 16/11/26 | CHF 0.1398 | +0.87% | 400,478 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RLF Stock
Select your edition
All financial news and data tailored to specific country editions
















